APA (7th ed.) Citation

L, F., L, M., M, M., O, M., T, F., & P, Z. (2026). Key Considerations in Evaluating Syphilis Therapeutics. Sexually transmitted diseases, 53(8), 523. https://doi.org/10.1097/OLQ.0000000000002349

Chicago Style (17th ed.) Citation

L, Frigati, Manning L, Marks M, Mitjà O, Fitzpatrick T, and Zhou P. "Key Considerations in Evaluating Syphilis Therapeutics." Sexually Transmitted Diseases 53, no. 8 (2026): 523. https://doi.org/10.1097/OLQ.0000000000002349.

MLA (9th ed.) Citation

L, Frigati, et al. "Key Considerations in Evaluating Syphilis Therapeutics." Sexually Transmitted Diseases, vol. 53, no. 8, 2026, p. 523, https://doi.org/10.1097/OLQ.0000000000002349.